Skip to main content

Rabbit Monoclonal Antibodies

  • Chapter
  • First Online:
Handbook of Practical Immunohistochemistry

Abstract

Rabbit monoclonal antibodies are relatively new in the immunohistochemistry (IHC) field. The majority of rabbit monoclonal antibodies are developed using a patented and proprietary rabbit hybridoma technology—the RabMAb® hybridoma technology. RabMAb primary antibodies offer greater advantages over classic mouse monoclonal antibodies, providing higher binding affinity, more diversified antigenic epitope recognition and a highly stable IgG structure. Since the inception of this technology in early 2000s, RabMAb primary antibodies have quickly replaced mouse monoclonal antibodies for several important markers such as HER2, c-kit/CD117, estrogen receptor and progesterone receptor in the pathology IHC field. RabMAb primary antibodies improve the effectiveness of certain markers that have been especially difficult in pathology IHC such as ERG, c-myc, bcl-2, MSH-6, MSH2 and PMS2. Because RabMAb primary antibodies offer superior sensitivity and specificity, performance reliability, as well as easy adaption to current automated stainers, it is clear that this group of antibodies is becoming the preferred choice for performing IHC in pathology laboratories.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

RabMAb® :

Rabbit monoclonal antibody developed using a patented and Epitomics’ proprietary rabbit hybridoma technology

References

  1. Spieker-Polet H, Sethupathi P, Yam PC, Knight KL. Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas. Proc Natl Acad Sci USA. 1995;92(20):9348–52.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Zhu W, Yu GL. Rabbit hybridoma. In: Andrew Z, editor. Therapeutic monoclonal antibodies: from bench to clinic. Hoboken, NJ: Wiley; 2009. p. 151–68.

    Chapter  Google Scholar 

  3. Mage RG, Lanning D, Knight KL. B cell and antibody repertoire development in rabbits: the requirement of gut-associated lymphoid tissues. Dev Comp Immunol. 2006;30(1–2):137–53.

    Article  CAS  PubMed  Google Scholar 

  4. Rossi S, Laurino L, Furlanetto A, et al. “Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies. Am J Pathol. 2005;124(2):295–302.

    CAS  Google Scholar 

  5. Barral DC, Brenner MB. CD1 antigen presentation: how it works. Nat Rev Immunol. 2007;7(12):929–41.

    Article  CAS  PubMed  Google Scholar 

  6. Huang Z, Zhu W, Szekeres G, Xia H. Development of new rabbit monoclonal antibody to estrogen receptor: immunohistochemical assessment on formalin-fixed, paraffin-embedded tissue sections. Appl Immunohistochem Mol Morphol. 2005;13(1):91–5.

    Article  CAS  PubMed  Google Scholar 

  7. Park K, Tomlins SA, Mudaliar KM, et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia. 2010;12(7):590–8.

    PubMed Central  CAS  PubMed  Google Scholar 

  8. Jain RK, Mehta R, Dimitrov R, et al. Atypical ductal hyperplasia: interobserver and intraobserver variability. Mod Pathol. 2011;24(7):917–23.

    Article  PubMed  Google Scholar 

  9. Williams AR, Piris J, Wyllie AH. Immunohistochemical demonstration of altered intracellular localization of c-MYC oncogene production in human colorectal neoplasms. J Pathol. 1990;160(4):287–93.

    Article  CAS  PubMed  Google Scholar 

  10. Kluk MJ, Chapuy B, Sinha P, et al. Immunohistochemical detection of MYC-driven diffuse large B-cell lymphomas. PLoS One. 2012;7(4):e33813.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Johnson NA, Savage KJ, Ludkovski O, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114(11):2273–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Nordic Immunohistocchemical Quality Control. http://www.nordiqc.org/Run-32-B11/Assessment/assessment-32-MSH6.htm. Accessed 22 May 2014.

  13. Mullard A. New checkpoint inhibitors ride the immunotherapy tsunami. Nat Rev Drug Discov. 2013;12(7):489–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Weimin Zhu MS, MBA .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zhu, W., Li, A., Chen, T. (2015). Rabbit Monoclonal Antibodies. In: Lin, F., Prichard, J. (eds) Handbook of Practical Immunohistochemistry. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1578-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1578-1_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1577-4

  • Online ISBN: 978-1-4939-1578-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics